+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shingles Vaccine Market by Vaccine Type (Recombinant Zoster Vaccine, Zoster Vaccine Live), Age Group (50 To 59 Years, 60 To 69 Years, 70 Years and Above), End User, Distribution Channel, Dosage - Global Forecast 2025-2030- Product Image
Shingles Vaccine Market by Vaccine Type (Recombinant Zoster Vaccine, Zoster Vaccine Live), Age Group (50 To 59 Years, 60 To 69 Years, 70 Years and Above), End User, Distribution Channel, Dosage - Global Forecast 2025-2030- Product Image
Sale

Shingles Vaccine Market by Vaccine Type (Recombinant Zoster Vaccine, Zoster Vaccine Live), Age Group (50 To 59 Years, 60 To 69 Years, 70 Years and Above), End User, Distribution Channel, Dosage - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716361
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The shingles vaccine market is undergoing rapid innovation as pharmaceutical manufacturers, healthcare organizations, and policy makers respond to changing demographics and regulatory landscapes. Proactive immunization strategies are increasingly vital for mitigating the burden of shingles among aging populations worldwide and driving operational efficiencies across global healthcare systems.

Market Snapshot: Shingles Vaccine Industry Overview

The shingles vaccine market grew from USD 1.87 billion in 2024 to USD 2.02 billion in 2025. It is projected to advance at a CAGR of 8.16%, reaching USD 2.99 billion by 2030. Primary drivers include rising incidence of herpes zoster among older adults, ongoing technological upgrades in vaccine development, and evolving regulatory guidelines shaping global adoption patterns.

Scope & Segmentation of the Shingles Vaccine Market

  • Vaccine Types:
    • Recombinant Zoster Vaccines
    • Live-Attenuated Zoster Vaccines
  • Age Groups:
    • 50 to 59 Years
    • 60 to 69 Years
    • 70 Years and Above
  • End Users:
    • Community Clinics
    • Private Clinics
    • General Hospitals
    • Specialty Hospitals
  • Distribution Channels:
    • Hospital Pharmacies
    • Digital Pharmacies
    • E-commerce Platforms
    • Chain Pharmacies
    • Independent Pharmacies
  • Dosage Formats:
    • Multi-dose Vials
    • Single-dose Presentations
  • Geographic Coverage:
    • Americas: United States, Canada, Mexico, Brazil, Argentina
    • EMEA: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies Analysed:
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • SK chemicals
    • GeneOne Life Science
    • CanSinoBIO
    • Moderna, Inc.
    • Chengdu Institute of Biological Products Co., Ltd.
    • Beijing Institute of Biological Products Co., Ltd.
    • Yuxi Walvax Biotechnology Co., Ltd.
  • Core Technologies:
    • Recombinant antigen platforms
    • Advanced adjuvant systems
    • mRNA-based vaccine research
    • Cold chain optimization
    • Digital engagement tools

Key Takeaways for Decision-Makers

  • Strong market momentum is being shaped by the aging population, heightening demand for effective shingles immunization pathways.
  • Innovations in recombinant vaccine technology and adjuvant systems yield improved safety and efficacy, supporting differentiated positioning for pharmaceutical brands.
  • Digital transformation and advanced analytics enhance vaccine deployment, supply chain resilience, and provider-patient engagement, especially in markets with infrastructure barriers.
  • Cross-sector collaborations and licensing deals facilitate faster product innovation and geographic expansion amid evolving public health recommendations.
  • Region-specific strategies are essential: while North America emphasizes reimbursement and public-private alliances, emerging markets in Asia-Pacific focus on expanding cold chain infrastructure and awareness initiatives.
  • Merger and acquisition activity is fostering portfolio consolidation and supporting strategic entry into new markets while enabling companies to respond quickly to demand fluctuations.

Tariff Impact: United States Trade Policies in 2025

New U.S. tariffs on pharmaceutical raw materials and specialized packaging for shingles vaccines have increased input costs, motivating vaccine producers to revisit global sourcing and manufacturing strategies. Companies are accelerating investments in domestic production and nearshoring, while building partnerships with local contract development and manufacturing organizations to manage cost fluctuation and maintain supply continuity. Regulatory and procurement teams are advocating for exemptions and pursuing agreements to stabilize pricing and ensure access, contributing to a more resilient but complex supply ecosystem.

Research Methodology & Data Sources

A rigorous methodology combined public literature review with targeted interviews, covering clinicians, regulatory advisors, and supply chain experts. Quantitative findings were validated by cross-referencing multiple data sources and scenario analysis, including SWOT and PESTEL frameworks, to ensure actionable, reliable guidance for stakeholders.

Why This Shingles Vaccine Market Report Matters

  • Enables senior decision-makers to benchmark technology adoption and anticipate trends across high-growth therapeutic and geographic segments.
  • Provides actionable segmentation to tailor product portfolios and commercial strategies for maximum impact in priority regions.
  • Supports policy advocacy and procurement planning by mapping regulatory changes and supply chain dynamics that affect operational continuity and market access.

Conclusion

The shingles vaccine market is entering a transformative phase, defined by scientific advances, cross-industry collaboration, and strategic agility. Stakeholders poised to leverage innovation will be best placed to address demand and capture long-term opportunities in immunization.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid global uptake of recombinant adjuvanted shingles vaccines in adults over 50
5.2. Integration of shingles immunization into routine adult vaccination schedules by national agencies
5.3. Growing investment in next generation herpes zoster vaccine candidates leveraging novel mRNA technology
5.4. Heightened focus on vaccine access programs in emerging markets to close shingles immunization gaps in seniors
5.5. Rising consumer awareness campaigns highlighting long term efficacy and safety profiles of newer shingles vaccines
5.6. Collaborative research partnerships between biotech start ups and big pharma to develop next generation zoster immunogens
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Shingles Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Recombinant Zoster Vaccine
8.3. Zoster Vaccine Live
9. Shingles Vaccine Market, by Age Group
9.1. Introduction
9.2. 50 To 59 Years
9.3. 60 To 69 Years
9.4. 70 Years And Above
10. Shingles Vaccine Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Community Clinics
10.2.2. Private Clinics
10.3. Hospitals
10.3.1. General Hospitals
10.3.2. Specialty Hospitals
11. Shingles Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Digital Pharmacies
11.3.2. E-commerce Platforms
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Shingles Vaccine Market, by Dosage
12.1. Introduction
12.2. Multi Dose
12.3. Single Dose
13. Americas Shingles Vaccine Market
13.1. Introduction
13.2. Argentina
13.3. Canada
13.4. United States
13.5. Brazil
13.6. Mexico
14. Europe, Middle East & Africa Shingles Vaccine Market
14.1. Introduction
14.2. South Africa
14.3. Qatar
14.4. Netherlands
14.5. Egypt
14.6. Finland
14.7. Switzerland
14.8. Nigeria
14.9. Denmark
14.10. United Arab Emirates
14.11. Norway
14.12. Saudi Arabia
14.13. Turkey
14.14. United Kingdom
14.15. Sweden
14.16. France
14.17. Italy
14.18. Spain
14.19. Israel
14.20. Poland
14.21. Germany
14.22. Russia
15. Asia-Pacific Shingles Vaccine Market
15.1. Introduction
15.2. Japan
15.3. Vietnam
15.4. South Korea
15.5. China
15.6. Philippines
15.7. Taiwan
15.8. Singapore
15.9. India
15.10. Malaysia
15.11. Australia
15.12. Indonesia
15.13. Thailand
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Merck & Co., Inc.
16.3.3. SK chemicals
16.3.4. GeneOne Life Science
16.3.5. CanSinoBIO
16.3.6. Moderna, Inc.
16.3.7. Chengdu Institute of Biological Products Co., Ltd.
16.3.8. Beijing Institute of Biological Products Co., Ltd.
16.3.9. Yuxi Walvax Biotechnology Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SHINGLES VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SHINGLES VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SHINGLES VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SHINGLES VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SHINGLES VACCINE MARKET: RESEARCHAI
FIGURE 26. SHINGLES VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. SHINGLES VACCINE MARKET: RESEARCHCONTACTS
FIGURE 28. SHINGLES VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SHINGLES VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SHINGLES VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT ZOSTER VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT ZOSTER VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ZOSTER VACCINE LIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ZOSTER VACCINE LIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 50 TO 59 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 50 TO 59 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 60 TO 69 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 60 TO 69 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 70 YEARS AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 70 YEARS AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SHINGLES VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SHINGLES VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DIGITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DIGITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SHINGLES VACCINE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SHINGLES VACCINE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SHINGLES VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SHINGLES VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SHINGLES VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SHINGLES VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 94. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 105. CANADA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. CANADA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. CANADA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. CANADA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. CANADA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. CANADA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. CANADA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. CANADA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. CANADA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. CANADA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. CANADA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. CANADA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 122. CANADA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. MEXICO SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. MEXICO SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 217. QATAR SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 218. QATAR SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 219. QATAR SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. QATAR SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. QATAR SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. QATAR SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. QATAR SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 224. QATAR SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 225. QATAR SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. QATAR SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. QATAR SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. QATAR SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. QATAR SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. QATAR SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. QATAR SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 232. QATAR SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 233. QATAR SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 234. QATAR SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 237. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 248. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 249. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 252. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 253. EGYPT SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 254. EGYPT SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 255. EGYPT SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 256. EGYPT SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 257. EGYPT SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. EGYPT SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. EGYPT SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. EGYPT SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. EGYPT SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 262. EGYPT SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 263. EGYPT SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. EGYPT SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. EGYPT SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. EGYPT SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. EGYPT SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 268. EGYPT SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 269. EGYPT SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 270. EGYPT SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 271. FINLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 272. FINLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 273. FINLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. FINLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. FINLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. FINLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. FINLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 278. FINLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 279. FINLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. FINLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. FINLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. FINLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FINLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. FINLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. FINLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. FINLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. FINLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 288. FINLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 289. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 290. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 291. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 298. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 299. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 306. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 325. DENMARK SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 326. DENMARK SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 328. DENMARK SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 329. DENMARK SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. DENMARK SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. DENMARK SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. DENMARK SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. DENMARK SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 334. DENMARK SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 335. DENMARK SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. DENMARK SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. DENMARK SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 338. DENMARK SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 339. DENMARK SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 340. DENMARK SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 341. DENMARK SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 342. DENMARK SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 345. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 346. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Shingles Vaccine market report include:
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • SK chemicals
  • GeneOne Life Science
  • CanSinoBIO
  • Moderna, Inc.
  • Chengdu Institute of Biological Products Co., Ltd.
  • Beijing Institute of Biological Products Co., Ltd.
  • Yuxi Walvax Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.99 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Shingles Vaccines - Global Strategic Business Report - Product Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • 269 Pages
  • Global
From
Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Adult Vaccines Market by Vaccine Type (Covid 19, Hepatitis, Herpes Zoster), Vaccine Technology (Conjugate, Dna, Inactivated), Route of Administration, Distribution Channel, Age Group - Global Forecast 2025-2030 - Product Image

Adult Vaccines Market by Vaccine Type (Covid 19, Hepatitis, Herpes Zoster), Vaccine Technology (Conjugate, Dna, Inactivated), Route of Administration, Distribution Channel, Age Group - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Shingrix (Zostavax) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Shingrix (Zostavax) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Zostavax Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Zostavax Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From

About the Shingles Vaccine Market

The Shingles Vaccine is a vaccine used to prevent shingles, a painful skin condition caused by the varicella-zoster virus. It is recommended for adults over the age of 50, and is available in both single-dose and two-dose formulations. The vaccine is typically administered by a healthcare provider, and is available in both private and public healthcare settings. The Shingles Vaccine market is a subset of the larger Vaccines market, which is estimated to be worth billions of dollars. The Shingles Vaccine market is expected to grow in the coming years, driven by an aging population and increased awareness of the condition. Some of the major companies in the Shingles Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.